 | • レポートコード：MRC2312MG00094 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の多発がん検出血液検査市場規模と予測を収録しています。・世界の多発がん検出血液検査市場：売上、2018年-2023年、2024年-2029年 ・世界の多発がん検出血液検査市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の多発がん検出血液検査市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ctDNA検査」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 多発がん検出血液検査のグローバル主要企業は、Galleri、 Amadix、 Burning Rock、 Exact Sciences、 Freenome、 AnchorDx、 Guardant Health、 Foundation Medicine、 GENECAST、 Coyne Medical、 Laboratory for Advanced Medicine、 Singlera Genomicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、多発がん検出血液検査のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の多発がん検出血液検査市場：タイプ別、2018年-2023年、2024年-2029年 世界の多発がん検出血液検査市場：タイプ別市場シェア、2022年 ・ctDNA検査、タンパク質バイオマーカー検査、メチル化検査、その他 世界の多発がん検出血液検査市場：用途別、2018年-2023年、2024年-2029年 世界の多発がん検出血液検査市場：用途別市場シェア、2022年 ・病院、検査機関、その他 世界の多発がん検出血液検査市場：地域・国別、2018年-2023年、2024年-2029年 世界の多発がん検出血液検査市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における多発がん検出血液検査のグローバル売上、2018年-2023年 ・主要企業における多発がん検出血液検査のグローバル売上シェア、2022年 ・主要企業における多発がん検出血液検査のグローバル販売量、2018年-2023年 ・主要企業における多発がん検出血液検査のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Galleri、 Amadix、 Burning Rock、 Exact Sciences、 Freenome、 AnchorDx、 Guardant Health、 Foundation Medicine、 GENECAST、 Coyne Medical、 Laboratory for Advanced Medicine、 Singlera Genomics ************************************************************* ・調査・分析レポートの概要 多発がん検出血液検査市場の定義 市場セグメント 世界の多発がん検出血液検査市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の多発がん検出血液検査市場規模 世界の多発がん検出血液検査市場規模：2022年 VS 2029年 世界の多発がん検出血液検査市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの多発がん検出血液検査の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の多発がん検出血液検査製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ctDNA検査、タンパク質バイオマーカー検査、メチル化検査、その他 多発がん検出血液検査のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、検査機関、その他 多発がん検出血液検査の用途別グローバル売上・予測 ・地域別市場分析 地域別多発がん検出血液検査市場規模 2022年と2029年 地域別多発がん検出血液検査売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Galleri、 Amadix、 Burning Rock、 Exact Sciences、 Freenome、 AnchorDx、 Guardant Health、 Foundation Medicine、 GENECAST、 Coyne Medical、 Laboratory for Advanced Medicine、 Singlera Genomics ... |
This research report provides a comprehensive analysis of the Multi-Cancer Detection Blood Test market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Multi-Cancer Detection Blood Test market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Multi-Cancer Detection Blood Test, challenges faced by the industry, and potential opportunities for market players.
The global Multi-Cancer Detection Blood Test market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Multi-Cancer Detection Blood Test market presents opportunities for various stakeholders, including Hospitals, Diagnostic Laboratories. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Multi-Cancer Detection Blood Test market. Additionally, the growing consumer demand present avenues for market expansion.
The global Multi-Cancer Detection Blood Test market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Multi-Cancer Detection Blood Test market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Multi-Cancer Detection Blood Test market.
Market Overview: The report provides a comprehensive overview of the Multi-Cancer Detection Blood Test market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., ctDNA-Based Tests, Protein Biomarker-Based Tests), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Multi-Cancer Detection Blood Test market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Multi-Cancer Detection Blood Test market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Multi-Cancer Detection Blood Test market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Multi-Cancer Detection Blood Test market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Multi-Cancer Detection Blood Test market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Multi-Cancer Detection Blood Test market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Multi-Cancer Detection Blood Test, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Multi-Cancer Detection Blood Test market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Multi-Cancer Detection Blood Test market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
ctDNA-Based Tests
Protein Biomarker-Based Tests
Methylation-Based Tests
Others
Market segment by Application
Hospitals
Diagnostic Laboratories
Others
Global Multi-Cancer Detection Blood Test Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Galleri
Amadix
Burning Rock
Exact Sciences
Freenome
AnchorDx
Guardant Health
Foundation Medicine
GENECAST
Coyne Medical
Laboratory for Advanced Medicine
Singlera Genomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multi-Cancer Detection Blood Test, market overview.
Chapter 2: Global Multi-Cancer Detection Blood Test market size in revenue and volume.
Chapter 3: Detailed analysis of Multi-Cancer Detection Blood Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multi-Cancer Detection Blood Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Multi-Cancer Detection Blood Test capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Multi-Cancer Detection Blood Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multi-Cancer Detection Blood Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multi-Cancer Detection Blood Test Overall Market Size
2.1 Global Multi-Cancer Detection Blood Test Market Size: 2022 VS 2029
2.2 Global Multi-Cancer Detection Blood Test Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Multi-Cancer Detection Blood Test Sales: 2018-2029
3 Company Landscape
3.1 Top Multi-Cancer Detection Blood Test Players in Global Market
3.2 Top Global Multi-Cancer Detection Blood Test Companies Ranked by Revenue
3.3 Global Multi-Cancer Detection Blood Test Revenue by Companies
3.4 Global Multi-Cancer Detection Blood Test Sales by Companies
3.5 Global Multi-Cancer Detection Blood Test Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Multi-Cancer Detection Blood Test Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Multi-Cancer Detection Blood Test Product Type
3.8 Tier 1, Tier 2 and Tier 3 Multi-Cancer Detection Blood Test Players in Global Market
3.8.1 List of Global Tier 1 Multi-Cancer Detection Blood Test Companies
3.8.2 List of Global Tier 2 and Tier 3 Multi-Cancer Detection Blood Test Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Multi-Cancer Detection Blood Test Market Size Markets, 2022 & 2029
4.1.2 ctDNA-Based Tests
4.1.3 Protein Biomarker-Based Tests
4.1.4 Methylation-Based Tests
4.1.5 Others
4.2 By Type – Global Multi-Cancer Detection Blood Test Revenue & Forecasts
4.2.1 By Type – Global Multi-Cancer Detection Blood Test Revenue, 2018-2023
4.2.2 By Type – Global Multi-Cancer Detection Blood Test Revenue, 2024-2029
4.2.3 By Type – Global Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
4.3 By Type – Global Multi-Cancer Detection Blood Test Sales & Forecasts
4.3.1 By Type – Global Multi-Cancer Detection Blood Test Sales, 2018-2023
4.3.2 By Type – Global Multi-Cancer Detection Blood Test Sales, 2024-2029
4.3.3 By Type – Global Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
4.4 By Type – Global Multi-Cancer Detection Blood Test Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Multi-Cancer Detection Blood Test Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Others
5.2 By Application – Global Multi-Cancer Detection Blood Test Revenue & Forecasts
5.2.1 By Application – Global Multi-Cancer Detection Blood Test Revenue, 2018-2023
5.2.2 By Application – Global Multi-Cancer Detection Blood Test Revenue, 2024-2029
5.2.3 By Application – Global Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
5.3 By Application – Global Multi-Cancer Detection Blood Test Sales & Forecasts
5.3.1 By Application – Global Multi-Cancer Detection Blood Test Sales, 2018-2023
5.3.2 By Application – Global Multi-Cancer Detection Blood Test Sales, 2024-2029
5.3.3 By Application – Global Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
5.4 By Application – Global Multi-Cancer Detection Blood Test Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Multi-Cancer Detection Blood Test Market Size, 2022 & 2029
6.2 By Region – Global Multi-Cancer Detection Blood Test Revenue & Forecasts
6.2.1 By Region – Global Multi-Cancer Detection Blood Test Revenue, 2018-2023
6.2.2 By Region – Global Multi-Cancer Detection Blood Test Revenue, 2024-2029
6.2.3 By Region – Global Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
6.3 By Region – Global Multi-Cancer Detection Blood Test Sales & Forecasts
6.3.1 By Region – Global Multi-Cancer Detection Blood Test Sales, 2018-2023
6.3.2 By Region – Global Multi-Cancer Detection Blood Test Sales, 2024-2029
6.3.3 By Region – Global Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Multi-Cancer Detection Blood Test Revenue, 2018-2029
6.4.2 By Country – North America Multi-Cancer Detection Blood Test Sales, 2018-2029
6.4.3 US Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.4.4 Canada Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.4.5 Mexico Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Multi-Cancer Detection Blood Test Revenue, 2018-2029
6.5.2 By Country – Europe Multi-Cancer Detection Blood Test Sales, 2018-2029
6.5.3 Germany Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.4 France Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.5 U.K. Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.6 Italy Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.7 Russia Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.8 Nordic Countries Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.9 Benelux Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Multi-Cancer Detection Blood Test Revenue, 2018-2029
6.6.2 By Region – Asia Multi-Cancer Detection Blood Test Sales, 2018-2029
6.6.3 China Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.6.4 Japan Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.6.5 South Korea Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.6.6 Southeast Asia Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.6.7 India Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Multi-Cancer Detection Blood Test Revenue, 2018-2029
6.7.2 By Country – South America Multi-Cancer Detection Blood Test Sales, 2018-2029
6.7.3 Brazil Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.7.4 Argentina Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Multi-Cancer Detection Blood Test Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Multi-Cancer Detection Blood Test Sales, 2018-2029
6.8.3 Turkey Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.8.4 Israel Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.8.5 Saudi Arabia Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.8.6 UAE Multi-Cancer Detection Blood Test Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Galleri
7.1.1 Galleri Company Summary
7.1.2 Galleri Business Overview
7.1.3 Galleri Multi-Cancer Detection Blood Test Major Product Offerings
7.1.4 Galleri Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.1.5 Galleri Key News & Latest Developments
7.2 Amadix
7.2.1 Amadix Company Summary
7.2.2 Amadix Business Overview
7.2.3 Amadix Multi-Cancer Detection Blood Test Major Product Offerings
7.2.4 Amadix Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.2.5 Amadix Key News & Latest Developments
7.3 Burning Rock
7.3.1 Burning Rock Company Summary
7.3.2 Burning Rock Business Overview
7.3.3 Burning Rock Multi-Cancer Detection Blood Test Major Product Offerings
7.3.4 Burning Rock Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.3.5 Burning Rock Key News & Latest Developments
7.4 Exact Sciences
7.4.1 Exact Sciences Company Summary
7.4.2 Exact Sciences Business Overview
7.4.3 Exact Sciences Multi-Cancer Detection Blood Test Major Product Offerings
7.4.4 Exact Sciences Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.4.5 Exact Sciences Key News & Latest Developments
7.5 Freenome
7.5.1 Freenome Company Summary
7.5.2 Freenome Business Overview
7.5.3 Freenome Multi-Cancer Detection Blood Test Major Product Offerings
7.5.4 Freenome Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.5.5 Freenome Key News & Latest Developments
7.6 AnchorDx
7.6.1 AnchorDx Company Summary
7.6.2 AnchorDx Business Overview
7.6.3 AnchorDx Multi-Cancer Detection Blood Test Major Product Offerings
7.6.4 AnchorDx Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.6.5 AnchorDx Key News & Latest Developments
7.7 Guardant Health
7.7.1 Guardant Health Company Summary
7.7.2 Guardant Health Business Overview
7.7.3 Guardant Health Multi-Cancer Detection Blood Test Major Product Offerings
7.7.4 Guardant Health Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.7.5 Guardant Health Key News & Latest Developments
7.8 Foundation Medicine
7.8.1 Foundation Medicine Company Summary
7.8.2 Foundation Medicine Business Overview
7.8.3 Foundation Medicine Multi-Cancer Detection Blood Test Major Product Offerings
7.8.4 Foundation Medicine Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.8.5 Foundation Medicine Key News & Latest Developments
7.9 GENECAST
7.9.1 GENECAST Company Summary
7.9.2 GENECAST Business Overview
7.9.3 GENECAST Multi-Cancer Detection Blood Test Major Product Offerings
7.9.4 GENECAST Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.9.5 GENECAST Key News & Latest Developments
7.10 Coyne Medical
7.10.1 Coyne Medical Company Summary
7.10.2 Coyne Medical Business Overview
7.10.3 Coyne Medical Multi-Cancer Detection Blood Test Major Product Offerings
7.10.4 Coyne Medical Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.10.5 Coyne Medical Key News & Latest Developments
7.11 Laboratory for Advanced Medicine
7.11.1 Laboratory for Advanced Medicine Company Summary
7.11.2 Laboratory for Advanced Medicine Business Overview
7.11.3 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Major Product Offerings
7.11.4 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.11.5 Laboratory for Advanced Medicine Key News & Latest Developments
7.12 Singlera Genomics
7.12.1 Singlera Genomics Company Summary
7.12.2 Singlera Genomics Business Overview
7.12.3 Singlera Genomics Multi-Cancer Detection Blood Test Major Product Offerings
7.12.4 Singlera Genomics Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.12.5 Singlera Genomics Key News & Latest Developments
8 Global Multi-Cancer Detection Blood Test Production Capacity, Analysis
8.1 Global Multi-Cancer Detection Blood Test Production Capacity, 2018-2029
8.2 Multi-Cancer Detection Blood Test Production Capacity of Key Manufacturers in Global Market
8.3 Global Multi-Cancer Detection Blood Test Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Multi-Cancer Detection Blood Test Supply Chain Analysis
10.1 Multi-Cancer Detection Blood Test Industry Value Chain
10.2 Multi-Cancer Detection Blood Test Upstream Market
10.3 Multi-Cancer Detection Blood Test Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Multi-Cancer Detection Blood Test Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
